Smith & Nephew PLC (SN.L)
24 Jan 2019
British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.
Dec 5 British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.
LONDON, Nov 1 Britain's Smith & Nephew expects its trading profit margin to be higher this year than last on a better performance for its hips franchise, boosting its shares.
LONDON, Nov 1 British medical products maker Smith & Nephew said it was on track to meet full-year guidance after growing quarterly revenues by 3 percent, on strong demand for its artificial hips and knees in the United States and emerging markets.
* But BATS, Relx, Smith & Nephew gain after updates (Adds closing prices)
LONDON, July 26 A drop in heavyweight oil stocks weighed on the UK's top share index, which failed to join a broader rally across European stocks on Thursday as U.S.-EU trade tensions thawed.
LONDON, July 26 Smith & Nephew, Europe's biggest artificial hip and knee maker, reiterated its full-year guidance on Thursday after its established markets returned to growth after a difficult start to the year.